mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Tech news from the best sources
The vaccine reportedly thwarted the cancer's return and spread.
It took just hours for the leading pharma group to reject the recommendations.